baber/WOPTO huggingface dataset:
Patent AU-776246-B2 (AU)
Title: Methods for introducing heterologous cells into fish
Inventor: SERBEDZIJA GEORGE N
IPC: C12Q1/68
Filed: 1999-11-30
Granted: 2004-09-02
Abstract: The invention provides methods of introducing heterologous cells into fish. After introduction cells remain viable, and in some instances proliferate, for sufficient time to conduct a variety of analyses on the heterologous cells or the fish or both. Such methods are useful for screening potential drugs for toxicity toward introduced cells or for capacity to stimulate differentiation and/or proliferation of introduced cells. Such methods are also useful for diagnosing the presence of small quantities of cancerous cells or pathogens in patient tissue samples. Such methods are also useful for culturing cells for subsequent use in cell or tissue engineering.
Patent AU-568827-B2 (AU)
Title: Fibre-optic amplifier
Inventor: SHAW HERBERT JOHN
IPC: G02B6/24
Filed: 1983-11-23
Granted: 1988-01-14
Abstract: A pair of small diameter optical fibres (14, 12) are arranged in a side-by-side configuration, the first fiber (14) doped with a material which will lase at the signal frequency, and the second fiber (12) providing a pumping source. The signal to be amplified propagates through the first fiber (14) to stimulate emission of coherent light from the lasing material, resulting in amplification of the signal. The refractive index of the first and second fibers (14, 12) are selected such that the signal in the first fiber (14) is well guided, while the pumping light in the second fiber (12) is unguided, yielding low losses in the first fiber (14) but high transfer of the pumping light from the second fiber (12) to the first fiber (14).
Patent AU-617117-B2 (AU)
Title: Substituted cycloalkanols
Inventor: STACK GARY PAUL
IPC: C07D239/42
Filed: 1988-09-13
Granted: 1991-11-21
Abstract: Compounds of the formula: <CHEM> in which m is one of the integers 1,2 or 3; n is one of the integers 0,1 or 2; o is one of the integers 0,1 or 2; R1 and R2 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, trifluoromethyl, halo, or, when taken together, 3,4-methylenedioxy; R3 is alkyl, <CHEM> where R4 and R5 are, independently, hydrogen, hydroxy;l, alkyl, alkoxy, alkanoyloxy, halo or trifluoromethyl; and R6 is hydrogen or halo; or a pharmaceutically acceptable salt thereof, are useful in treatment of psychiatric disorders.
Patent AU-688493-B2 (AU)
Title: A detection system
Inventor: TOWERS PAUL
IPC: G01S7/4911
Filed: 1995-04-25
Granted: 1998-03-12
Abstract: PCT No. PCT/GB95/00933 Sec. 371 Date Oct. 24, 1996 Sec. 102(e) Date Oct. 24, 1996 PCT Filed Apr. 25, 1995 PCT Pub. No. WO95/28996 PCT Pub. Date Nov. 2, 1995A detection system for detecting the position of an object of a movable member and, In particular, for detection the position of a ball in a moving roulette wheel which has a light source for emitting visible light which is modulated. A sensor is provided to receive reflections of the emitted modulated light from the ball and the moving roulette wheel. The reflections are analyzed to determine the position of the member and the location of the objection in relation thereto. The light source can transmit light and the sensor can detect specific similarly modulated wavelengths which are predetrmined dependent upon the relative chrominance of the number ring and the pocket ring of the wheel.
Patent AU-604970-B2 (AU)
Title: Improved battery terminal and method
Inventor: ADAMS DAVID W
IPC: H01M50/172
Filed: 1988-09-28
Granted: 1991-01-03
Abstract: A battery terminal post of the type for use in electrolytic devices contained by resilient electrolyte-resistant walls, wherein an opening (16) in the electrolytic device wall is radially enlarged to form a bushing (27), into which is inserted a second T-shaped lead alloy bushing (14), into which in turn there is inserted a complementary third bushing (12) of pure lead, which three bushings are then forced into intimate sealing contact by being radially expanded by the action of a punch and die in a swaging operation.
Patent AU-711085-B2 (AU)
Title: Computerized quotation system and method
Inventor: GIOVANNOLI JOSEPH
IPC: G06Q30/08
Filed: 1997-02-21
Granted: 1999-10-07
Abstract: A computerized system for forming a computer based communications network of network members inclusive of network buyers and or network vendors for processing requests for quotation for goods and services through at least one central processing unit including operating system software for controlling the central processing unit, storage means containing the identification of network members, means for network buyers to generate request for quotation for goods and/or services, means for transmitting said request for quotation to said central processing unit, filter means for selecting appropriate network members to receive said request for quotation based on filter conditions defined by the buyer in said request for quotation and/or by the vendor and/or by the central processing unit, means for broadcasting said request for quotation to the network members selected by said filter means and means for responding to the generator of said request for quotation with either a response to said request for quotation or with a list of said selected network members. Filter conditions may define the class of vendors in terms of geographical location, quantity, language spoken, currency, special conditions of sale, and the like.
Patent AU-745772-B2 (AU)
Title: Chemical compounds
Inventor: BARKER ANDREW JOHN
IPC: A61P43/00
Filed: 1999-02-02
Granted: 2002-03-28
Abstract: A pharmaceutical composition which comprises a compound of formula (I)or a pharmaceutically acceptable salt, ester or amide thereof, which is an inhibitor of monocyte chemoattractant protein-1, and wherein A and B form an optionally substituted alkylene chain so as to form a ring with the carbon atoms to which they are attached; X is CH2 or SO2, R1 is an optionally substituted aryl or heteroaryl ring; R2 is a specified organic group such as carboxy, and R3 is hydrogen or a specified organic group; in combination with a pharmaceutically acceptable carrier. Certain compounds of formula (I) are novel and are claimed as such.
Patent AU-777039-B2 (AU)
Title: Locking system and flooring board
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2002-03-13
Granted: 2004-09-30
Abstract: The invention relates to a locking system for mechanical joining of floorboards (1) along a vertical joint plane (F), and a floorboard comprising such a locking system. For joining perpendicular to the joint plane (F) there is a locking groove formed in the underside (3) of a first joint edge at a distance from the joint plane (F), and a portion (P) projecting from the lower part of the second joint edge (4a) and below the first joint edge and, at a distance from the joint plane (F), supporting a locking element (8) cooperating with the locking groove (14), said projecting portion (2) thus being located entirely outside the joint plane (F). The projecting portion (P) presents at least two horizontally juxtaposed parts (P1, P2), which differ from each other in respect of at least one of the parameters material composition and material properties.
Patent AU-781192-B2 (AU)
Title: Nucleic acid amplification and detection of mycobacterium species
Inventor: BRENTANO STEVEN T
IPC: C12Q1/689
Filed: 1999-12-17
Granted: 2005-05-12
Abstract: Oligonucleotides used to prime in vitro nucleic acid amplification of 16S rRNA sequences or DNA encoding 16S rRNA sequences for many species within the genus    Mycobacterium     are disclosed. Kits including such oligonucleotides are disclosed. Methods of detecting    Mycobacterium     species using the oligonucleotides in in vitro nucleic acid amplification are disclosed.
Patent AU-655673-B2 (AU)
Title: High content ibuprofen agglomerates and process to prepare them
Inventor: ATKIN GRAHAM JOHN
IPC: A61K47/36
Filed: 1992-08-25
Granted: 1995-01-05
Abstract: PCT No. PCT/EP92/01953 Sec. 371 Date Mar. 4, 1994 Sec. 102(e) Date Mar. 4, 1994 PCT Filed Aug. 25, 1992 PCT Pub. No. WO93/04676 PCT Pub. Date Mar. 18, 1993.A process for the preparation of a pharmaceutical composition in the form of agglomerates comprising 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a pharmaceutically acceptable salt thereof and 3-30% by weight of a starch component, said process comprising the steps of a) forming an emulsion comprising 1) 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a salt thereof 2) a solvent system 3) 3-30% by weight of the starch component 4) water and optionally 5) a surfactant b) crystallising to produce a suspension comprising crystals of 2-(4-isobutylphenyl)propionic acid or the salt thereof in intimate contact with the starch component c) agitating said suspension to form agglomerates comprising an evenly distributed mixture of 2-(4-isobutylphenyl)propionic acid or a salt thereof and the starch component d) collecting said agglomerates and optionally e) drying said agglomerates. Pharmaceutical formulations comprising 90-99.98% by weight of such a composition together with 0.02-10% of a pharmaceutically acceptable excipient are also described, which are suitable for direct compression into tablets.
Patent AU-653864-B2 (AU)
Title: Call control method for a radio system
Inventor: LOPPONEN JUSSI
IPC: H04W76/06
Filed: 1992-09-24
Granted: 1994-10-13
Abstract: PCT No. PCT/FI92/00263 Sec. 371 Date Jun. 3, 1993 Sec. 102(e) Date Jun. 3, 1993 PCT Filed Sep. 24, 1992 PCT Pub. No. WO/9307685 PCT Pub. Date Apr. 15, 1993.A call control method for a radio system, wherein a half-duplex type mobile station (MS1, MS2) is commanded so as to clear a call on the radio channel of a base station (BS), by transmitting a disconnect signal to the mobile station (MS1, MS2) over the radio channel, the mobile station leaving the radio channel upon receiving the disconnect signal. In order to ensure that the disconnect signal is received by the mobile station, the field intensity received by the base station (BS) on the radio channel is measured immediately after the transmission of the disconnect signal, and the radio channel is released for the next call only when the measured field intensity falls below a predetermined threshold value.
Patent AU-561507-B2 (AU)
Title: Injector nozzle bore bushing for prevention of thermal fatigue cracking
Inventor: HEWLITT ROBERT W
IPC: F02F1/38
Filed: 1984-05-14
Granted: 1987-05-07
Abstract: A load carrying assembly is disclosed for an internal combustion engine. The engine includes an engine block having a cylinder formed therein and having a cylinder head mounted onto the block. The cylinder head has a deck surface which closes off one end of the cylinder. A piston is reciprocally mounted in the cylinder and cooperates with the deck surface to form a combustion chamber. Air and combustion gases enter and exit the combustion chamber through intake and exhaust passages formed in the cylinder head and which terminate into intake and exhaust ports formed in the deck surface. The outer peripheries of the adjacent intake and exhaust ports form a bridge section therebetween having a maximum length which is less than twice the diameter of the larger of the intake and exhaust ports. Formed at least partially within the bridge section is a nozzle bore which also communicates with the combustion chamber. A sleeve having an enlarged portion on its outside diameter, is permanently fixed within the cylinder head such that one end will be aligned approximately adjacent to the deck surface of the cylinder head. The sleeve serves as a load carrying member which reduces the initiation of thermal cracks in the bridge section between the outer circumference of the nozzle bore and the outer peripheries of the intake and exhaust ports, respectively.
Patent AU-564326-B2 (AU)
Title: 1,4-dihydro-quinoline and 1,4-dihydro-1,8-naphthyridine derivatives
Inventor: SOLER JOSE ESTEVE
IPC: A61K31/435
Filed: 1984-06-15
Granted: 1987-08-06
Abstract: The present invention relates to new derivatives of 7-(1-pyrrolyl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(1-pyrrolyl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid of general formula I:    <IMAGE>  (I)  in which: X represents a carbon atom or a nitrogen atom, and R represents a hydrogen atom or a fluorine atom, as well as their physiologicaly acceptable alkali metal salts or alkaline earth metal salts. The derivatives of the present invention are advantageously used as antimicrobial agents, espcially as anti-bacterial and anti-fungal agents.
Patent AU-696294-B2 (AU)
Title: Complete self-contained multipurpose dairy processor unit for milk derivatives production
Inventor: MUZZARELLI GABRIELE
IPC: A01K1/00
Filed: 1995-08-01
Granted: 1998-09-03
Abstract: PCT No. PCT/EP95/03062 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed Aug. 1, 1995 PCT Pub. No. WO96/04782 PCT Pub. Date Feb. 22, 1996A complete self-containing multipurpose dairy processor unit in which a liquid is treated including a hot-water or steam generator and a heat exchanger immersible in the liquid to be treated and selectively feedable when immersed in the liquid being treated with hot water, steam or cold water depending on whether heat is to be transferred to the liquid to be treated or removed from the liquid to be treated, the hot water or steam being produced by the generator device. A generator including a turbine produces a flow within the liquid to be treated to cause the liquid to pass over the heat exchanger. The turbine is a variable-speed turbine which forces the liquid from a location below the heat exchanger upward into and through the heat exchanger.
Patent AU-689321-B2 (AU)
Title: Beverage container with self-contained drinking straw
Inventor: MURPHY PETER F
IPC: B65D47/06
Filed: 1995-09-06
Granted: 1998-03-26
Abstract: A beverage container having a straw-dispensing mechanism that is disposed within the container and is responsive to appropriate manipulation of the container to bring the straw into alignment with the orifice in the top end of the container. The straw is supported by a weighted member that responds to the manipulation of the container to move the straw. A float is attached to the straw to elevate the straw through the orifice when the straw is aligned with the orifice. Several alternative embodiments of the invention are disclosed.
Patent AU-672400-B2 (AU)
Title: Method for dyeing keratin fibres in an alkaline medium by means of 2-substituted para-aminophenols combined with 6- or 7-hydroxyindole, and compositions therefor
Inventor: COTTERET JEAN
IPC: A61K8/41
Filed: 1993-04-07
Granted: 1996-10-03
Abstract: A method for dyeing keratin fibres by applying at least one para-aminophenol of formula (I), wherein Y is oxygen or sulphur, and R is alkyl, monohydroxyalkyl or polyhydroxyalkyl, and acid addition salts thereof, as well as 6-hydroxyindole and/or 7-hydroxyindole, the colour being revealed at alkaline pH by means of an oxidizing agent.
Patent AU-758948-B2 (AU)
Title: Multiple section orthotic or prosthetic sleeve of varying elasticity
Inventor: EINARSSON PALMI
IPC: A61F13/00
Filed: 2000-03-01
Granted: 2003-04-03
Abstract: An orthotic or prosthetic sleeve includes at least two elasticized fabric elements having different elastic stiffnesses in orthogonal directions connected together to form a tubular sleeve such that the direction of higher stiffness of one fabric element extends parallel with the sleeve axis and the direction of higher stiffness of the other element extends generally transversely of the sleeve axis. A three piece tubular sleeve may be arranged so that the middle section has a direction of higher stiffness extending transversely of the sleeve axis, with the end sections having the higher stiffness direction extending parallel with the sleeve axis.
Patent AU-772880-B2 (AU)
Title: Wound therapy device
Inventor: LINA CESAR Z
IPC: A61M1/00
Filed: 2000-04-07
Granted: 2004-05-13
Abstract: A process for making a porous pad (36) for providing a reduced pressure in a therapeutic apparatus for stimulating the healing of a wound is described. The process comprises providing a porous pad (36) having pores greater than 100 microns in diameter, reducing a portion of the pores to a size of 100 microns or less in diameter, and providing an opening in the pad for receipt of a vacuum tube.
Patent AU-766869-B2 (AU)
Title: Homogenising of small-volume mixtures by centrifugation and heating
Inventor: MALMQVIST MATS
IPC: C12N15/09
Filed: 2000-03-24
Granted: 2003-10-23
Abstract: The efficient temperation of a sample is achieved when the sample is subjected to centrifugation simultaneously wish heating and optionally also cooling. This is achieved in a device comprising at least a rotor (1) for holding reaction vessels (2), a motor (3), connected to the rotor, a processor (4) for controlling the speed of the rotor, and elements (5 and 6) for heating and cooling the contents of the reaction vessels, wherein the elements (6) for heating cover the apices of the reaction vessels for at least part of the rotational path of the vessels and that the elements for heating operate at a temperature significantly higher than the meeting temperature of the reaction vessels. The invention further relates to a method for performing chemical reactions and in particular a method for performing biochemical reactions involving thermocycling, for example PCR-reactions.
Patent AU-580059-B2 (AU)
Title: Vaccine against rabies and preparation process thereof
Inventor: LATHE RICHARD
IPC: A61K39/42
Filed: 1985-04-24
Granted: 1988-12-22
Abstract: Virus of the vaccina characterized in that it comprises all or part of an ADN(I) sequence coding for an antigenic glycoprotein of rabies.
Patent AU-578467-B2 (AU)
Title: GRF Analogs IV
Inventor: VALE WYLIE WALKER JR
IPC: G01N33/68
Filed: 1985-05-15
Granted: 1988-10-27
Abstract: Human GRF(hGRF), rat GRF(rGRF), porcine GRF(pGRF) and bovine GRF(bGRF) have been earlier characterized and synthetized. The invention provides synthetic peptides which are extremely potent in stimulating the release of pituitary GH in animals, including humans, which have resistance to enzymatic degradation in the body, and which have the sequence: R1-R2-R3-Ala-Ile-Phe-Thr-R8-Ser-R10-Arg-R12-R13-R14-R15-Gln-R17-R18-Al a-Arg-Lys-Le u-R23-R24-R25-Ile-R27-R28-R29-Gln-Gln-Gly-Glu-R34-Asn-Gln-Glu-R38-R39- R40-Arg-R42- R43-R44 wherein R1 is Tyr, D-Tyr, Met, Phe, D-Phe, pCl-Phe, Lou, His or D-His having either a C< alpha >Me or N< alpha >Me substitution or being unsubstituted; R2 is Ala, D-Ala or D-NMA; R3 is Asp or D-Asp; R8 is Ser, Asn, D-Ser or D-Asn; R10 is Tyr or D-Tyr; R12 is Arg or Lys; R13 is Ile or Val; R14 is Leu or D-Leu; R15 is Gly or D-Ala; R17 is Leu or D-Leu; R18 is Tyr or Ser; R23 is Leu or D-Leu; R24 is His or Gln; R25 is Glu, Asp, D-Glu or D-Asp; R27 is Met, D-Met, Ala, Nle, Ile, Leu, Nva or Val; R28 is Asn or Ser; R29 is Arg or D-Arg; R34 is Arg or Ser; R34 is Gln or Arg; R39 is Arg or Gly; R40 is Ser or Ala; R42 is Phe, Ala or Val; R43 is Asn or Arg; R44 is a natural amino acid; provided however that any or all of the residues between R28 and R44, inclusive, may be deleted and provided also that R2 is D-NMA and/or R14 is D-Leu and/or R29 in is D-Arg. Those peptides as well as their nontoxic salts may also be used diagnostically.
Patent AU-619349-B2 (AU)
Title: Quinolinone derivatives, their preparation and their application in therapy
Inventor: MANOURY PHILIPPE
IPC: A61K31/47
Filed: 1989-10-10
Granted: 1992-01-23
Abstract: Quinolinone derivatives corresponding to the formula (I) 
<IMAGE>
 in which each of R1 and R2, independently of each other, is a hydrogen or halogen atom or a C1-4 alkyl radical,
 R3 is a hydrogen atom or a C1-4 alkyl radical,
 R4 is a naphthyl, tetrahydronaphthyl, benzyl, phenyl, pyridyl, isoquinolyl or benzoyl radical, it being possible for these radicals to carry a substituent such as methoxy, chlorine or fluorine,
 each of X and Y is a hydrogen atom or together they form a bond, and their salts of addition to pharmaceutically acceptable acids. 
<??>Application in therapy.
Patent AU-763889-B2 (AU)
Title: Hyperforin derivatives, the use thereof and formulations containing them
Inventor: BOMBARDELLI EZIO
IPC: A61P25/24
Filed: 1999-06-04
Granted: 2003-07-31
Abstract: Hyperforin derivatives of formula I <CHEM> <??>wherein R is an acyl or a glicoside group, have advantageous pharmacological characteristics and good stability, and are used for the preparation of an antidepressive medicament.
Patent AU-629252-B2 (AU)
Title: Polysiloxane-polyurethanes and contact lenses thereof
Inventor: HARISIADES PAUL
IPC: C08G18/10
Filed: 1989-10-27
Granted: 1992-10-01
Abstract: A novel polysiloxane polyurethane is described which is obtained by reaction of an isocyanate capped polysiloxane prepolymer with a polysiloxane-disilanol and which contains O-silyl-urethane linkages. The novel polysiloxane-polyurethanes are useful as oxygen permeable membranes or films, as bandages and drug carriers, for example in transdermal drug delivery, and especially as highly oxygen permeable, soft contact lenses.
Patent AU-783113-B2 (AU)
Title: Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier
Inventor: TAKEZAWA TOSHIAKI
IPC: C12N5/074
Filed: 2001-04-02
Granted: 2005-09-22
Abstract: Provided are a cell culture carrier for animal cells, for which is used a tissue section alone or a tissue section stuck to a support or stuck thereto while stretched; and a method of using the carrier for culture and transplantation of cells. The cell culture carrier provides a culture environment that is more similar to that in living tissue, or that is, it provides such a culture environment that involves the intended, site and time-dependent information on living tissue. Culturing animal cells on the tissue-derived culture carrier makes it possible to analyze the properties and the characteristics of the cultured cells on the basis of the interaction between the cells and the site and time-dependent information on the tissue of the carrier, to analyze the function of genes on the basis of the interaction there between, to reconstruct a novel engineered tissue by utilizing the carrier tissue as a template, and to transplant the reconstructed tissue.
Patent AU-724218-B2 (AU)
Title: Preparation for transporting active ingredients through barriers
Inventor: CEVC GREGOR
IPC: A61K31/192
Filed: 1996-10-17
Granted: 2000-09-14
Abstract: A composition (A) comprises liquid droplets suspended in a fluid (A) for the transport of at least one active agent, especially for medicinal or biological use, into and through barriers and constrictions such as the skin. The droplets are surrounded by a membrane-type shell made of one or a few layers of amphiphilic carrier substances (I). There are at least two, (Ia) and (Ib), carrier substances with different physico-chemical properties. (Ia) and (Ib) have solubilities in the suspension medium (usually water) that differ by a factor of at least 10. The content of solubilising components is less than 0.1 mol.%, based on the content of (I), so that the solubilising point of the droplets with shells is reached or the solubilising point cannot be reached. Also claimed is a process for the preparation of (A), where the content of amphiphilic components is chosen so that the permeability of (A) through constrictions is at least 10-5 of the permeability of small molecules, such as water.
Patent AU-576620-B2 (AU)
Title: Hexedine-zinc salt oral composition
Inventor: SIPOS TIBOR
IPC: A61K8/23
Filed: 1985-08-29
Granted: 1988-09-01
Abstract: Oral compositions which exhibit antimicrobial activity containing hexedine and a pharmaceutically acceptable zinc compound.